UC-San Francisco: Uncovering Why Cancer Immunotherapy Leads to Heart Inflammation
January 08, 2026
January 08, 2026
SAN FRANCISCO, California, Jan. 8 (TNSjou) -- The University of California San Francisco campus issued the following news release:
* * *
Uncovering Why Cancer Immunotherapy Leads to Heart Inflammation
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using a patient's own T-cells to target tumors. However, they can cause rare but potentially fatal cardiac inflammation known as ICI-myocarditis. This is particularly true in the . . .
* * *
Uncovering Why Cancer Immunotherapy Leads to Heart Inflammation
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using a patient's own T-cells to target tumors. However, they can cause rare but potentially fatal cardiac inflammation known as ICI-myocarditis. This is particularly true in the . . .